 
 |
Dr. Mark Dykewicz (allergy and immunology) was interviewed by Fitness Magazine regarding new physician guidelines for allergy treatment. (See story on page 5.) The story will appear in an upcoming issue.
Carol Needham (law) was quoted extensively in the Dec. 8 issue of U.S. Law Week on her talk regarding the pitfalls presented to in-house counsel by the unauthorized practice of law doctrine. She delivered the talk to the American Corporate Counsel Association's annual meeting in Washington, D.C.
Dr. R. Gregory Evans (Public Health) was interviewed by American News Service regarding his research into a lead poisoning prevention study funded by the Centers for Disease Control. The American News Service is a national news wire that syndicates to papers as large as the Chicago Tribune and as small as hometown weekly papers.
Brendan Stack, M.D. (otolaryngology) was interviewed by USA Today Magazine about his research into a tumor marker to help identify head and neck cancers.
Jerry Katz (management) was interviewed by Fortune for a story about interest rate cuts.
Joel Goldstein (law) was interviewed by the Associated Press for a story about Vice President Al Gore's support of the president during the recent scandal.
Dr. Richard Bucholz (neurosurgery) is featured in the Life magazine special issue titled "Medical Miracles." Bucholz is quoted in the article "Gene Therapy," one of the 21 medical miracles highlighted in the issue. The article includes excerpts and photography from a feature article published by Discover magazine that focused on an experimental gene therapy treatment for the deadly glioblastoma brain tumor. Discover author Jeff Goldberg and medical photographer Max Aguilera-Hellweg followed Bucholz through the surgical procedure, where a disabled herpes simplex virus was injected into the tumor site. The treatment is designed so that the virus infects dividing cells, leaving normal brain cells unaffected. Once infected, the cells are killed by giving the patient the antiviral drug ganciclovir, which attacks the herpes virus, thus eliminating the infected cancer cells.
  |